BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36420057)

  • 1. Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome.
    Kong W; Ma J; Lin Y; Chen W
    Cardiovasc Ther; 2022; 2022():2484018. PubMed ID: 36420057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study.
    Waleed KB; Tse G; Lu YK; Peng CN; Tu H; Ding LG; Xia YL; Wu SL; Li XT; Zhou HQ; Chen QY; Sun AM; Altaf A; Chang JL; Wang LL
    Rev Cardiovasc Med; 2021 Mar; 22(1):231-238. PubMed ID: 33792267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
    Koay YC; Chen YC; Wali JA; Luk AWS; Li M; Doma H; Reimark R; Zaldivia MTK; Habtom HT; Franks AE; Fusco-Allison G; Yang J; Holmes A; Simpson SJ; Peter K; O'Sullivan JF
    Cardiovasc Res; 2021 Jan; 117(2):435-449. PubMed ID: 32267921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasm trimethylamine-N-oxide level and association with lesion severity in coronary heart disease patients with type 2 diabetes mellitus].
    Zhang YN; Wang SM; Yu X; Zhang WD; Wang XY; Yang RY; Chen WX; Dong J; Ji FS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jul; 49(7):680-686. PubMed ID: 34256435
    [No Abstract]   [Full Text] [Related]  

  • 5. Neither Trimethylamine-N-Oxide nor Trimethyllysine Is Associated with Atherosclerosis: A Cross-Sectional Study in Older Japanese Adults.
    Bhuiya J; Notsu Y; Kobayashi H; Shibly AZ; Sheikh AM; Okazaki R; Yamaguchi K; Nagai A; Nabika T; Abe T; Yamasaki M; Isomura M; Yano S
    Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases.
    Spasova N; Somleva D; Krastev B; Ilieva R; Borizanova A; Svinarov D; Kinova E; Goudev A
    Biosci Rep; 2024 Apr; 44(5):. PubMed ID: 38669041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Eyileten C; Jarosz-Popek J; Jakubik D; Gasecka A; Wolska M; Ufnal M; Postula M; Toma A; Lang IM; Siller-Matula JM
    Front Cardiovasc Med; 2021; 8():728724. PubMed ID: 34778397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.
    Goyal BM; Sharma SM; Walia M
    Indian Heart J; 2014; 66(2):183-7. PubMed ID: 24814112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome.
    Ringel C; Dittrich J; Gaudl A; Schellong P; Beuchel CF; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Büttner P; Löffler M; Scholz M; Thiery J; Ceglarek U
    Atherosclerosis; 2021 Oct; 335():62-67. PubMed ID: 34583200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
    Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
    BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of atherosclerosis on vascular structures in patients with acute coronary syndrome.
    Kalay N; Yarlioglues M; Ardic I; Duran M; Kaya MG; Inanc T; Dogan A; Koç F; Ciçek D; Kasapkara A; Celik A; Topsakal R; Oguzhan A; Ergin A
    Clin Invest Med; 2010 Feb; 33(1):E36-43. PubMed ID: 20144268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
    Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
    Bao M; Li H; Li J
    BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].
    Yuan S; Pu T; Wang Z; Li L; Gao P; Zhang L; Ma Y; Qi Q; Fan X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Mar; 34(3):274-279. PubMed ID: 35574745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography.
    Liu X; Xie Z; Sun M; Wang X; Li J; Cui J; Zhang F; Yin L; Huang D; Hou J; Tian J; Yu B
    Int J Cardiol; 2018 Aug; 265():18-23. PubMed ID: 29729869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma sLRP-1 Level Independently Relates to a Higher Risk of Moderate-Severe Stenosis by Gensini Score in Acute Coronary Syndrome Patients.
    Qin W; Xue W; Nie J; Tian Y; Zhu L; Liu J; Yu H; Lv X; Feng C; Liu J; Bu H; Yuan F
    Tohoku J Exp Med; 2023 Aug; 260(4):329-336. PubMed ID: 37258136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
    Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
    J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients.
    Ling Y; Weng H; Tang S
    BMC Cardiovasc Disord; 2021 Dec; 21(1):578. PubMed ID: 34861824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Prealbumin with Angiographic Severity in Patients with Acute Coronary Syndrome.
    Zhang C; Liu P; Xia K; Fang H; Jiang M; Xie Q; Yu Z; Yang T
    Med Sci Monit; 2017 Aug; 23():4041-4049. PubMed ID: 28827514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.